Feedback / Questions
APR-1051 - Aprea
https://www.globenewswire.com/news-release/2026/04/21/3278152/0/en/Aprea-Therapeutics-to-Provide-Clinical-Update-on-ACESOT-1051-Phase-1-Trial-Evaluating-WEE1-Inhibitor-APR-1051-at-ASCO-2026-Annual-Meeting.html
Apr 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next